In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Dial Consumer President, CEO

This article was originally published in The Rose Sheet

Executive Summary

Dial Consumer President, CEO: Will be Malcolm Jozoff, 57, effective upon completion of Dial Corp.'s split into two independent, publicly traded companies -- Dial Consumer Products and a yet-to-be named services company. The split-up, which was announced Feb. 15, is expected to be completed in the third quarter. Jozoff's resume includes 25 years at Procter & Gamble, where he eventually served as president of the worldwide health care division. From 1993-1995, he held the position of chairman and CEO of china and dinnerware manufacturer Lenox. John Teets, Dial Corp. chairman and CEO, will assume the position of chairman, president and CEO of the services sector after the separation. Dial Corp. President Andrew Patti will remain in his current position until the split-up, according to the company...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002839

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel